Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-06-04 @ 7:31 AM
Study NCT ID:
NCT00865605
Status:
COMPLETED
Last Update Posted:
2010-08-17
First Post:
2009-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DP03-689
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Christine Winslow, Director of Clinical Development
Old Organization:
Actavis Inc